14 insiders reported 146 Form 4 transactions for Maze Therapeutics, Inc. (MAZE) over the past 18 months (most recent 2026-09-08). Recent activity: Bernstein Harold (President, R&D & CMO) Sell 9,705 shares, Bernstein Harold (President, R&D & CMO) Sell 5,130 shares, Courtney Phillips (GC and Corp. Secretary) Sell 1,738 shares, Dandekar Atul (CSBO) Sell 2,800 shares, Bernstein Harold (President, R&D & CMO) Sell 4,481 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Bernstein Harold | President, R&D & CMO | Sell | 9,705 | $254,502 |
| 2026-09-04 | Bernstein Harold | President, R&D & CMO | Sell | 5,130 | $133,448 |
| 2026-09-04 | Courtney Phillips | GC and Corp. Secretary | Sell | 1,738 | $45,841 |
| 2026-09-04 | Dandekar Atul | CSBO | Sell | 2,800 | $73,853 |
| 2026-09-04 | Bernstein Harold | President, R&D & CMO | Sell | 4,481 | $118,191 |
| 2026-09-04 | Coloma Jason V | Chief Executive Officer | Sell | 1,375 | $37,292 |
| 2026-09-04 | Courtney Phillips | GC and Corp. Secretary | Sell | 243 | $6,590 |
| 2026-09-04 | Dandekar Atul | CSBO | Sell | 391 | $10,604 |
| 2026-09-04 | Bernstein Harold | President, R&D & CMO | Sell | 625 | $16,951 |
| 2026-09-04 | Coloma Jason V | Chief Executive Officer | Sell | 11,282 | $293,482 |
| 2026-09-04 | Courtney Phillips | GC and Corp. Secretary | Sell | 1,990 | $51,766 |
| 2026-09-04 | Dandekar Atul | CSBO | Sell | 3,207 | $83,425 |
| 2026-09-04 | Coloma Jason V | Chief Executive Officer | Sell | 9,852 | $259,856 |
| 2026-09-04 | Coloma Jason V | Chief Executive Officer | Sell | 129 | $3,325 |
| 2026-09-04 | Courtney Phillips | GC and Corp. Secretary | Sell | 22 | $567 |
| 2026-09-04 | Dandekar Atul | CSBO | Sell | 36 | $929 |
| 2026-09-04 | Bernstein Harold | President, R&D & CMO | Sell | 59 | $1,521 |
| 2026-09-03 | Coloma Jason V | Chief Executive Officer | Sell | 2,593 | $68,214 |
| 2026-09-03 | Courtney Phillips | GC and Corp. Secretary | Buy | 11,000 | $0 |
| 2026-09-03 | Dandekar Atul | CSBO | Buy | 12,500 | $0 |
| 2026-09-03 | Bernstein Harold | President, R&D & CMO | Buy | 16,141 | $168,189 |
| 2026-09-03 | Coloma Jason V | Chief Executive Officer | Sell | 31,908 | $838,785 |
| 2026-09-03 | Bernstein Harold | President, R&D & CMO | Sell | 16,141 | $425,512 |
| 2026-09-03 | Coloma Jason V | Chief Executive Officer | Buy | 50,000 | $0 |
| 2026-09-03 | Bernstein Harold | President, R&D & CMO | Buy | 20,000 | $0 |
Source: SEC Form 4 filings · as of 2026-09-08